China leads in next-gen CAR-T trials, but regulatory changes could slow testing
Nature reports that China tests CAR-T therapies faster than the rest of the world, though regulatory changes could slow that pace.
TLDR
Nature says China leads the world in trials for next-generation CAR-T therapies and tests CAR-T therapies faster than the rest of the world. It reports that regulatory changes could slow that pace.
Combined views
10.7K
1 Source, first seen 2h ago
59 likes